For the year ending 2025-12-31, OPRX has $176,918K in assets. $48,624K in debts. $23,365K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 23,365 | |||
| Accounts receivable, net of allowance for credit losses of 260 and 335 at december31, 2025 and 2024, respectively | 37,752 | |||
| Taxes receivable | 752 | |||
| Prepaid expenses and other | 2,846 | |||
| Total current assets | 64,715 | |||
| Property and equipment | 457 | |||
| Less accumulated depreciation | 351 | |||
| Property and equipment, net | 106 | |||
| Goodwill | 70,869 | |||
| Patent rights, net | 4,586 | |||
| Technology assets, net | 6,870 | |||
| Tradename and customer relationships, net | 29,340 | |||
| Operating lease right-of-use assets | 404 | |||
| Security deposits and other assets | 28 | |||
| Total other assets | 112,097 | |||
| Total assets | 176,918 | |||
| Current portion of long-term debt | 4,255 | |||
| Accounts payable | 1,636 | |||
| Accrued expenses | 11,591 | |||
| Revenue share payable | 3,086 | |||
| Taxes payable | 0 | |||
| Current portion of lease liabilities | 193 | |||
| Deferred revenue | 503 | |||
| Total current liabilities | 21,264 | |||
| Long-term debt, net | 21,421 | |||
| Lease liabilities, net of current portion | 234 | |||
| Deferred tax liabilities, net | 5,705 | |||
| Total liabilities | 48,624 | |||
| Common stock, 0.001 par value, 166,666,667 shares authorized, 20,500,986 and 20,194,697 shares issued at december31, 2025 and 2024, respectively | 20 | |||
| Treasury stock, 0.001 par value,1,741,397 shares purchased at december31, 2025 and 2024 | 2 | |||
| Additional paid-in-capital | 207,512 | |||
| Accumulated deficit | -79,236 | |||
| Total stockholders equity | 128,294 | |||
| Total liabilities and stockholders equity | 176,918 | |||
OptimizeRx Corp (OPRX)
OptimizeRx Corp (OPRX)